This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Afimmune Limited. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: Kevin Duffy: Innovator in Liver Disease Treatments from Dublin, IE
Introduction
Kevin Duffy is a distinguished inventor based in Dublin, Ireland, known for his contributions to the field of medicine with a focus on liver disease treatments. With a total of two patents to his name, he has developed innovative solutions aimed at addressing chronic health issues.
Latest Patents
Duffy's most recent patents include groundbreaking formulations. The first patent, titled "Compositions comprising 15-HEPE and methods of using the same," focuses on the treatment of fatty liver disorders, specifically non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). This invention discusses compositions that utilize 15-OHEPA to significantly alleviate these conditions.
The second patent, "Compositions comprising 15-HEPE and methods of treating or preventing fibrosis using same," outlines methodologies and formulations for treating and preventing fibrosis in patients requiring such interventions. These inventions are pivotal in providing new avenues for patient care and improving the quality of life for those affected by liver diseases.
Career Highlights
Kevin Duffy works at Afimmune Limited, where he contributes his expertise and innovative spirit to the team. His career is marked by a commitment to advancing medical research and improving therapeutic approaches through his patented inventions. As a dedicated inventor, Duffy continues to push the boundaries of science and technology to enhance patient outcomes.
Collaborations
Throughout his career, Duffy has collaborated with esteemed colleagues, including Jonathan Rowe and John Climax. These partnerships have fostered a productive environment that encourages the exchange of ideas and advancements in research, ultimately benefiting his invention endeavors.
Conclusion
Kevin Duffy exemplifies the role of an inventor dedicated to addressing critical medical challenges. His patents on 15-HEPE compositions not only showcase his innovative capabilities but also hold the potential to make significant contributions to the treatment of liver disease. Through his work at Afimmune Limited and his collaborations with fellow professionals, Duffy continues to pave the way for advancements in healthcare innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile